Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

Recruiting Early Phase 1 Interventional Study
Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 80
Sex
Any
Trial phase
Early Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
42 (estimated)
Sponsor
Teachers College, Columbia University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn whether noise-augmented feedback using automatic speech recognition improves intelligibility and social participation in individuals with Parkinson's disease. The main questions the investigators will address are: Does noise-augmented feedback lead to increased intelligibility, as measured by transcription accuracy scores? Does a self-managed speech pr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Participants will qualify for the study if: * They are 50-80 years old, * They have a medical diagnosis of PD, * They are within stages I-IV of Hoehn \& Yahr Scale, * Their antiparkinsonian medication schedule is stable, * They present with mild to moderate dysarthr…
Contacts

Gemma Moya-Galé, Ph.D.

212-678-3323

gm2446@tc.columbia.edu

CONTACT